News

Genital Herpes Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 The report provides a detailed analysis of the current genital herpes marketed drugs ...
A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...
Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...
A genetically modified herpes simplex virus, called RP1, has now been shown to destroy advanced melanoma tumors, even when ...
University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically ...
Modified Herpes Virus as a Weapon Against Skin Cancer? A new study suggests it might work—even for metastases deep within the ...
The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...
One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.
Assembly Biosciences has dosed the first subject in the Phase Ia/b study’s Phase Ib portion, evaluating ABI-1179.
What the shingles vaccine does is it dampens reactivations of latent viruses in a way that may be protecting other parts of your body,” Martin said. Including, it seems, the brain. The measles, mumps ...
Could common viruses silently influence your brain health? Discover what new research reveals about herpes and dementia.
New imaging tools reveal how within an hour of infection, the virus begins to alter our chromosomes to kick-start its own replication.